[Monitoring the treatment of precocious puberty with a GnRH-analog (buserelin): comparison of the GnRH-test with nocturnal pulsatility of LH, testosterone and 17-beta-estradiol]

Pediatr Med Chir. 1991 Sep-Oct;13(5):471-4.
[Article in Italian]

Abstract

We studied in 10 children (3 boys and 7 girls), affected by precocious puberty and treated for a period of more than 6 months with the GnRH-analog Buserelin, the efficacy of the GnRH test versus the study of spontaneous nocturnal secretion of LH, testosterone and 17 beta-estradiol as a means of testing the gonadotropin suppression. All the subjects have shown a total suppression of LH during the GnRH test as well as a nocturnal profile of LH, testosterone and 17 beta-estradiol of a prepubertal pattern. Clinically all the patients were treated successfully. Considering the effectiveness of both investigations, we conclude that the GnRH test combined with clinical observation is a single and valid means of testing the pharmacological treatment for precocious puberty.

Publication types

  • English Abstract

MeSH terms

  • Buserelin / therapeutic use*
  • Child
  • Child, Preschool
  • Circadian Rhythm
  • Drug Monitoring / methods*
  • Estradiol / blood
  • Female
  • Gonadal Steroid Hormones / blood*
  • Gonadotropin-Releasing Hormone*
  • Humans
  • Luteinizing Hormone / blood*
  • Male
  • Puberty, Precocious / blood
  • Puberty, Precocious / drug therapy*
  • Testosterone / blood

Substances

  • Gonadal Steroid Hormones
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Estradiol
  • Luteinizing Hormone
  • Buserelin